PERSERIS 120 mg in 0.8 mL Prefilled Syringe
RxNorm 2055672
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2055672 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PERSERIS 120 mg in 0.8 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
0.8 mL Perseris 150 mg/ML Prefilled Syringe
(Atom ID: 10331775)
SBDPrescribable
Semantic Branded Drug (SBD):
0.8 mL risperidone 150 mg/ML Prefilled Syringe [Perseris]
(Atom ID: 12364188)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
0.8 mL risperiDONE 150 mg/ML Prefilled Syringe [Perseris]
(Atom ID: 10332080)
PSNPrescribable
Prescribable Name (PSN):
PERSERIS 120 mg in 0.8 mL Prefilled Syringe
(Atom ID: 10331774)
SYPrescribable
Synonym (SY):
Perseris 120 mg per 0.8 mL Prefilled Syringe
(Atom ID: 10331776)
Patient Education
Risperidone Injection
Risperidone extended-release (long-acting) injection is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection is used alone or in combination with lithium (Lithobid) or valproate (Depacon) to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.